Please Wait.....
Report
North America Colorectal Cancer Market to 2027 - Regional Analysis and Forecasts by Modality (Diagnosis Type, Therapy Type, Imaging Type); End User (Hospitals, Diagnostic and Research Laboratories), and Country
Market Report I 2022-09-23 I 157 Pages I The Insight Partners
The colorectal cancer market in North America is expected to grow from US$ 8,559.27 million in 2022 to US$ 11,198.11 million by 2028; it is estimated to grow at a CAGR of 3.4% from 2022 to 2028.
Colorectal cancer is one of the most commonly found lethal cancers in individuals with the combined influence of genetic and environmental factors. A significant population in North America is diagnosed with colorectal cancer. According to the Centers for Disease Control and Prevention (CDC) and the American Cancer Society, an estimated 1.93 million adults in the US were diagnosed with colon and rectum cancer, and 53,200 deaths were caused by colorectal cancer in 2020. These statistics showcase increased demand for advanced cancer diagnostics and therapeutics in the region. Thus, the rising prevalence of colorectal cancer and the rising number of patients diagnosed with the disease are driving the growth of the North America colorectal cancer market.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America colorectal cancer market at a substantial CAGR during the forecast period.
North America Colorectal Cancer Market Revenue and Forecast to 2028 (US$ Million)
North America Colorectal Cancer Market Segmentation
The North America colorectal cancer market is segmented into modality, end user, and country. Based on modality, the North America colorectal cancer market is segmented into diagnosis type, therapy type, and imaging type. In 2022, the diagnosis type segment held the largest market share and is expected to register the highest CAGR during the forecast period. Based on end user, the North America colorectal cancer market is bifurcated into hospitals and diagnostic & research laboratories. In 2022, the hospitals segment held a larger market share. Based on country, the North America colorectal cancer market is segmented into the US, Canada, and Mexico. The US held the largest market share in 2022.
Abbott, Amgen Inc., Bruker Corporation, Clinical Genomics Technologies Pty Ltd., Epigenomics AG, F. Hoffmann-La Roche AG, Quest Diagnostics, and VolitionRx Limited are among the leading companies operating in the North America colorectal cancer market.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Colorectal Cancer Market - By Modality
1.3.2 North America Colorectal Cancer Market - By End User
1.3.3 North America Colorectal Cancer Market - By Country
2. North America Colorectal Cancer Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Colorectal Cancer- Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Expert Opinion
5. North America Colorectal Cancer Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Colorectal Cancer
5.1.2 New Product Launches
5.1.3 Benefits Offered by Generic Drugs
5.2 Market Restraints
5.2.1 Pricing Pressure on Drug Manufacturers
5.3 Future Trends
5.3.1 Inclination Toward Personalized Medicine
5.4 Impact Analysis
6. North America Colorectal Cancer Market- North America Analysis
6.1 North America Colorectal Cancer Market Revenue Forecast and Analysis
6.1.1 Overview
7. North America Colorectal Cancer Market Analysis - By Modality
7.1 Overview
7.2 North America Colorectal Cancer Market Revenue Share, By Modality 2022 & 2028 (%)
7.3 Diagnosis Type
7.3.1 Overview
7.3.2 Diagnosis Type: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.3.3 Immunohistochemistry
7.3.3.1 Overview
7.3.3.2 Immunohistochemistry: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.3.4 Stool Test
7.3.4.1 Overview
7.3.4.2 Stool Test: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.3.5 Flexible Sigmoidoscopy
7.3.5.1 Overview
7.3.5.2 Flexible Sigmoidoscopy: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.3.6 Colonoscopy
7.3.6.1 Overview
7.3.6.2 Colonoscopy: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.3.7 CEA Test
7.3.7.1 Overview
7.3.7.2 CEA Test: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.3.8 Other Test
7.3.8.1 Overview
7.3.8.2 Other Test: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Therapy Type
7.4.1 Overview
7.4.2 North America Therapy Type: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4.3 Chemotherapy
7.4.3.1 Overview
7.4.3.2 Chemotherapy: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4.3.3 Alkylating Agent
7.4.3.3.2 Overview
7.4.3.3.3 Alkylating Agent: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4.3.4 Antimetabolites
7.4.3.4.2 Antimetabolites: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4.3.5 Others
7.4.3.5.2 Others: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4.4 Immunotherapy
7.4.4.1 Overview
7.4.4.2 Immunotherapy: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4.4.3 Panitumumab
7.4.4.3.2 Overview
7.4.4.3.3 Panitumumab: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4.4.4 Cetuximab
7.4.4.4.2 Overview
7.4.4.4.3 Cetuximab: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4.4.5 Bevacizumab
7.4.4.5.2 Overview
7.4.4.5.3 Bevacizumab: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4.4.6 Others
7.4.4.6.2 Overview
7.4.4.6.3 Others: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4.5 Chemoprotectant
7.4.5.1 Overview
7.4.5.2 Chemoprotectant: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.4.6 Others
7.4.6.1 Overview
7.4.6.2 Others: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Imaging Type
7.5.1 Overview
7.5.2 North America Imaging Type: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.5.3 Computed Tomography (CT)
7.5.3.1 Overview
7.5.3.2 Computed Tomography (CT): Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.5.4 Magnetic Resonance Imaging (MRI)
7.5.4.1 Overview
7.5.4.2 Magnetic Resonance Imaging (MRI): Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
7.5.5 Others
7.5.5.1 Overview
7.5.5.2 Others: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
8. North America Colorectal Cancer Market Revenue and Forecast To 2028 - By End User
8.1 Overview
8.2 North America Colorectal Cancer Market Revenue Share, By End User 2022 & 2028 (%)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Diagnostic and Research Laboratories
8.4.1 Overview
8.4.2 Diagnostic and Research Laboratories: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
9. North America Colorectal Cancer Market Revenue and Forecast to 2028 - Country Analysis
9.1 North America: Colorectal Cancer Market
9.1.1 Overview
9.1.2 North America: Colorectal Cancer Market, by Country, 2022 & 2028 (%)
9.1.2.1 US: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
9.1.2.1.2 US: Colorectal Cancer Market Revenue and Forecast to 2028 (US$ Million)
9.1.2.1.3 US: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
9.1.2.1.3.1 US: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
9.1.2.1.3.2 US: Colorectal Cancer Market, by Therapy Type- 2019- 2028 (US$ Million)
9.1.2.1.3.2.1 US: Colorectal Cancer Market, by Chemotherapy- 2019-2028 (US$ Million)
9.1.2.1.3.2.2 US: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
9.1.2.1.3.3 US: Colorectal Cancer Market, by Imaging Type - 2019-2028 (US$ Million)
9.1.2.1.4 US: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.1.2.2 Canada: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
9.1.2.2.2 Canada: Colorectal Cancer Market Revenue and Forecast to 2028 (US$ Million)
9.1.2.2.3 Canada: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
9.1.2.2.3.1 Canada: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
9.1.2.2.3.1.1 Canada: Colorectal Cancer Market, by Therapy Type - 2019- 2028 (US$ Million)
9.1.2.2.3.1.2 Canada: Colorectal Cancer Market, by Chemotherapy- 2019-2028 (US$ Million)
9.1.2.2.3.2 Canada: Colorectal Cancer Market, by Imaging Type - 2019-2028 (US$ Million)
9.1.2.2.4 Canada: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
9.1.2.3 Mexico: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
9.1.2.3.2 Mexico: Colorectal Cancer Market Revenue and Forecast to 2028 (US$ Million)
9.1.2.3.3 Mexico: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
9.1.2.3.3.1 Mexico: Colorectal Cancer Market, by Diagnosis Type - 2019-2028 (US$ Million)
9.1.2.3.3.2 Mexico: Colorectal Cancer Market, by Therapy Type - 2019- 2028 (US$ Million)
9.1.2.3.3.2.1 Mexico: Colorectal Cancer Market, by Chemotherapy- 2019-2028 (US$ Million)
9.1.2.3.3.2.2 Mexico: Colorectal Cancer Market, by Immunotherapy- 2019- 2028 (US$ Million)
9.1.2.3.3.3 Mexico: Colorectal Cancer Market, by Imaging Type - 2019-2028 (US$ Million)
9.1.2.3.4 Mexico: Colorectal Cancer Market - Revenue and Forecast To 2028, By End Users (US$ Million)
10. Colorectal Cancer Market - Industry Landscape
10.1 Overview
10.2 Growth Strategies In The Colorectal Cancer Market, 2022-2028
10.3 Organic Developments
10.3.1 Overview
10.3.2 Organic Growth Strategies In The Colorectal Cancer Market, 2022-2028
10.4 Inorganic Developments
10.4.1 Overview
10.4.2 Inorganic Growth Strategies In The Colorectal Cancer Market, 2022-2028
11. Company Profiles
11.1 Epigenomics AG
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Clinical Genomics Technologies Pty. Ltd.
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Abbott
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Amgen Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 F. HOFFMANN-LA ROCHE LTD.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Bruker Corporation
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Quest Diagnostics Incorporated
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Volitionrx Limited
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
Table 1. US: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
Table 2. US: Colorectal Cancer Market, by Diagnosis Type - Revenue and Forecast to 2028 (US$ Million)
Table 3. US: Colorectal Cancer Market, by Therapy Type - Revenue and Forecast to 2028 (US$ Million)
Table 4. US: Colorectal Cancer Market, by Chemotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 5. US: Colorectal Cancer Market, by Immunotherapy- Revenue and Forecast To 2028 (US$ Million)
Table 6. US: Colorectal Cancer Market, by Imaging Type - Revenue and Forecast to 2028 (US$ Million)
Table 7. US: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
Table 8. Canada: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
Table 9. Canada: Colorectal Cancer Market, by Diagnosis Type - Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada: Colorectal Cancer Market, by Therapy Type - Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada: Colorectal Cancer Market, by Chemotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada: Colorectal Cancer Market, by Immunotherapy- Revenue and Forecast To 2028 (US$ Million)
Table 13. Canada: Colorectal Cancer Market, by Imaging Type - Revenue and Forecast to 2028 (US$ Million)
Table 14. Canada: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
Table 15. Mexico: Colorectal Cancer Market - Revenue and Forecast to 2028, By Modality (US$ Million)
Table 16. Mexico: Colorectal Cancer Market, by Diagnosis Type - Revenue and Forecast to 2028 (US$ Million)
Table 17. Mexico: Colorectal Cancer Market, by Therapy Type - Revenue and Forecast to 2028 (US$ Million)
Table 18. Mexico: Colorectal Cancer Market, by Chemotherapy - Revenue and Forecast to 2028 (US$ Million)
Table 19. Mexico: Colorectal Cancer Market, by Immunotherapy- Revenue and Forecast To 2028 (US$ Million)
Table 20. Mexico: Colorectal Cancer Market, by Imaging Type - Revenue and Forecast to 2028 (US$ Million)
Table 21. Mexico: Colorectal Cancer Market - Revenue and Forecast To 2028, By End Users (US$ Million)
Table 22. Recent Organic Growth Strategies In The Colorectal Cancer Market
Table 23. Recent Inorganic Growth Strategies In The Colorectal Cancer Market
Table 24. Glossary of Terms, North America Colorectal Cancer Market
LIST OF FIGURES
Figure 1. North America Colorectal Cancer Market Segmentation
Figure 2. North America Colorectal Cancer Segmentation, By Country
Figure 3. North America Colorectal Cancer Market Overview
Figure 4. Diagnosis Type Segment Held Largest Share Of Modality Segment In North America Colorectal Cancer Market
Figure 5. US is Expected To Show Remarkable Growth During The Forecast Period
Figure 6. North America Colorectal Cancer Market - PEST Analysis
Figure 7. Comparison of Branded Drugs and Generic Drugs
Figure 8. North America Colorectal Cancer Market Impact Analysis of Drivers And Restraints
Figure 9. North America Colorectal Cancer Market - Revenue Forecasts And Analysis - 2020- 2028
Figure 10. North America Colorectal Cancer Market Revenue Share, by Modality 2022 & 2028 (%)
Figure 11. North America Diagnosis Type: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. North America Immunohistochemistry: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. North America Stool Test: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. North America Flexible Sigmoidoscopy: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 15. North America Colonoscopy: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. North America CEA Test: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. North America Other Test: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. North America Therapy Type: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. North America Chemotherapy: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Alkylating Agent: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. North America Antimetabolites: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. North America Others: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. North America Immunotherapy: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. North America Panitumumab: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. North America Cetuximab: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. North America Bevacizumab: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. North America Others: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. North America Chemoprotectant: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. North America Others: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. North America Imaging Type: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. North America Computed Tomography (CT): Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 32. North America Magnetic Resonance Imaging (MRI): Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. North America Others: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 34. North America Colorectal Cancer Market Revenue Share, by End User 2022 & 2028 (%)
Figure 35. North America Hospitals: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 36. North America Diagnostic and Research Laboratories: Colorectal Cancer Market - Revenue and Forecast to 2028 (US$ Million)
Figure 37. North America: Colorectal Cancer Market Revenue Overview, By Key Country - Revenue (2022) (US$ Million)
Figure 38. North America: Colorectal Cancer Market, By Country, 2022 & 2028 (%)
Figure 39. US: Colorectal Cancer Market Revenue and Forecast To 2028 (US$ Million)
Figure 40. Canada: Colorectal Cancer Market Revenue and Forecast To 2028 (US$ Million)
Figure 41. Mexico: Colorectal Cancer Market Revenue and Forecast To 2028 (US$ Million)
Figure 42. Growth Strategies In The Colorectal Cancer Market, 2022-2028
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security